Canadian researchers have discovered that the neglected diabetes drug – AC253 has a potential to restore the memory in brain cells affected by Alzheimer’s. The study on laboratory rodents published this year in the Journal of Neuroscience shines a spark of hope upon those who fight against the disease. Perhaps the new treatment will not only be able to stop the progress but also to reverse the damage caused by it. Read full text »

Alzheimer’s disease is a type of dementia that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time, becoming severe enough to interfere with daily tasks. A brain scan identifies biochemical changes in the brains of normal people, who might be at risk for Alzheimer’s Disease. Results of new study have been published in Neurology, the medical journal of the American Academy of Neurology. Read full text »